Details for Patent: 7,901,385

« Back to Dashboard

Which drugs does patent 7,901,385 protect, and when does it expire?

Patent 7,901,385 protects SUMAVEL DOSEPRO and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 7,901,385

Title:	Casing
Abstract:	A casing (50) for an injection device (10) of the type having a safety device which prevents operation of the device (10), incorporating an actuator means (56) by which the safety means of the device (10) can be actuated to allow operation of the device (10). Also a casing (50) for a medicament container having an opening closed prior to use by a break-off tip (135), having relatively moveable first and second casing parts (51, 52), which on relative movement apply a breaking force to the break-off tip (135). A preferred embodiment includes both such features.
Inventor(s):	Anderson; Gregor John McLennan (Ware, GB), Mitchell; John (London, GB)
Assignee:	Zogenix, Inc. (Emeryville, CA)
Application Number:	10/506,959
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,901,385
Patent Claim Types: see list of patent claims	Use; Device; Dosage form;

Drugs Protected by US Patent 7,901,385

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Ventures Ltd	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 7,901,385

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0206560.5	Mar 20, 2002

PCT Information
PCT Filed	March 18, 2003	PCT Application Number:	PCT/EP03/02876
PCT Publication Date:	September 25, 2003	PCT Publication Number:	WO03/077973

International Family Members for US Patent 7,901,385

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2003219086	➤ Sign Up
Canada	2479316	➤ Sign Up
Germany	60315429	➤ Sign Up
European Patent Office	1487517	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.